Overview
Michel Amar-Henry practices practicing medicine in Caen, France.
Mr. Amar-Henry is highly rated in 1 condition, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Anal Cancer, and Non-Hodgkin Lymphoma.
He is actively involved in clinical research, co-authoring 17 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Michel Amar-Henry
Is Michel Amar-Henry a top-rated expert for Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Michel Amar-Henry is classified as an Advanced expert for Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Michel Amar-Henry participate in research or clinical trials?
Yes. Michel Amar-Henry has published 17 articles and abstracts on conditions like Hodgkin Lymphoma. You can view a list of Michel Amar-Henry's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hodgkin LymphomaMr. Amar-Henry isAdvanced. Learn about Hodgkin Lymphoma.
- Experienced
- Anal CancerMr. Amar-Henry isExperienced. Learn about Anal Cancer.
- Non-Hodgkin LymphomaMr. Amar-Henry isExperienced. Learn about Non-Hodgkin Lymphoma.